Follow
Kevin Chang
Kevin Chang
MD-PhD Student, University of Chicago
Verified email at uchicago.edu
Title
Cited by
Cited by
Year
Masking the immunotoxicity of interleukin-12 by fusing it with a domain of its receptor via a tumour-protease-cleavable linker
A Mansurov, P Hosseinchi, K Chang, AL Lauterbach, LT Gray, AT Alpar, ...
Nature Biomedical Engineering 6 (7), 819-829, 2022
412022
Tumor cell-surface binding of immune stimulating polymeric glyco-adjuvant via cysteine-reactive pyridyl disulfide promotes antitumor immunity
AJ Slezak, A Mansurov, MM Raczy, K Chang, AT Alpar, AL Lauterbach, ...
ACS Central Science 8 (10), 1435-1446, 2022
142022
Therapeutic synthetic and natural materials for immunoengineering
A Slezak, K Chang, S Hossainy, A Mansurov, SJ Rowan, JA Hubbell, ...
Chemical Society Reviews, 2024
12024
Thermoreversibly Assembled Polymersomes for Highly Efficient Loading, Processing, and Delivery of Protein and siRNA Biologics
J Hubbell, S Hossainy, S Kang, JG Medellín, A Alpar, K Refvik, Y Ma, ...
2024
Cysteine-binding adjuvant enhances survival and promotes immune function in a murine model of acute myeloid leukemia
AJ Slezak, K Chang, TN Beckman, KC Refvik, AT Alpar, AL Lauterbach, ...
Blood Advances, bloodadvances. 2023012529, 2024
2024
Engineered IL-7 synergizes with IL-12 immunotherapy to prevent T cell exhaustion and promote memory without exacerbating toxicity
S Kang, A Mansurov, T Kurtanich, HR Chun, AJ Slezak, LR Volpatti, ...
Science Advances 9 (48), eadh9879, 2023
2023
Membrane-localized neoantigens predict the efficacy of cancer immunotherapy
Z Goldberger, S Hauert, K Chang, T Kurtanich, AT Alpar, G Repond, ...
Cell Reports Medicine 4 (8), 2023
2023
Prophylactic and therapeutic use of synthetically glycosylated antigens to limit allergic airway disease
JEG Medellin, TWM Ung, TR Kurtanich, JW Reda, T Wang, K Chang, ...
The Journal of Immunology 210 (1_Supplement), 67.23-67.23, 2023
2023
55P Mutations localized at the membrane predict immunotherapeutic efficacy in cancer treatment
Z Goldberger, S Hauert, K Chang, T Kurtanich, AT Alpar, JA Hubbell, ...
Immuno-Oncology and Technology 16, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–9